Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:WAB
NYSE:WABMachinery

How Westinghouse’s Record Backlog and Upbeat Q1 Outlook Could Shape Westinghouse Air Brake (WAB) Investors

Westinghouse Air Brake Technologies recently announced it will report its fiscal Q1 2026 results on April 22, 2026, following a period of upbeat guidance and a record backlog that has drawn strong attention from analysts and institutional investors. The company’s consistent record of topping earnings estimates, combined with optimistic 2026 earnings guidance and broad analyst “Outperform” views, has become a central factor in shaping market expectations for its upcoming results. With...
NasdaqGS:SANM
NasdaqGS:SANMElectronic

Is JPMorgan's Cautious View Reframing Sanmina's (SANM) Cyclical Risk and Margin Narrative?

Recently, JPMorgan initiated coverage on electronics manufacturing services provider Sanmina with a Neutral rating, emphasizing the company’s exposure to cyclical industrial markets and relatively slower gross margin expansion versus peers. This new coverage contrasts with generally positive analyst sentiment and highlights how differing views on Sanmina’s earnings quality and end‑market risk profile can shape investor expectations. We’ll now examine how JPMorgan’s caution around Sanmina’s...
NYSE:BBAI
NYSE:BBAIIT

A Look At BigBear.ai Holdings (BBAI) Valuation After Revenue Weakness And Cautious 2026 Guidance

BigBear.ai Holdings (BBAI) is back in focus after proposing an amendment to double its authorized common stock to 1,000,000,000 shares, alongside recent pressure from a 37.71% year-over-year revenue decline. See our latest analysis for BigBear.ai Holdings. The share price reaction has been harsh in the short term, with a 16.59% 1 month share price decline and a 41.44% year to date share price decline. However, the 1 year total shareholder return of 9.27% and 3 year total shareholder return of...
NYSE:BE
NYSE:BEElectrical

Will Bloom Energy’s New AI‑Savvy CFO Reframe the Long‑Term Power Story for BE Investors?

In March 2026, Bloom Energy announced that Simon Edwards, a veteran finance leader with experience at Groq, Conga, ServiceMax, and GE, would become its Chief Financial Officer effective April 13, 2026, bringing expertise in scaling technology, digital infrastructure, and operational systems. The appointment underscores Bloom’s push to align its financial leadership with rising demand for resilient onsite power as AI data centers, manufacturers, and healthcare providers seek faster, more...
SEHK:3988
SEHK:3988Banks

Assessing Bank Of China (SEHK:3988) Valuation After Resilient Full Year Earnings

Bank of China (SEHK:3988) has just reported full year 2025 results, showing net income of CNY 243,021 million and net interest income of CNY 440,705 million. These figures quickly put profitability and capital returns in focus for shareholders. See our latest analysis for Bank of China. The latest earnings release, bond redemption and recent earnings call appear to have supported sentiment. The latest share price is HK$5.06, with a 30 day share price return of 10.96% and a 5 year total...
NYSE:NRG
NYSE:NRGElectric Utilities

What NRG Energy (NRG)'s Discounted Secondary Offering and CEO Transition Means For Shareholders

NRG Energy recently faced pressure after a March secondary offering of 14.3 million shares by LS Power affiliates at a discount, alongside leadership uncertainty tied to the upcoming April 30 CEO transition and insider selling by the incoming chief executive. These governance and ownership shifts are unfolding just as analysts are reassessing NRG’s earnings outlook, highlighting how capital structure and leadership changes can influence confidence in its long-term power and home services...
ENXTBR:FLUX
ENXTBR:FLUXOil and Gas

Is Fluxys Belgium (ENXTBR:FLUX) Overvalued After Recent Share Price Weakness And Mixed Cash Flow Signals

Without a specific news event triggering the move, Fluxys Belgium (ENXTBR:FLUX) is drawing attention as investors reassess its recent share performance and the underlying gas transmission, storage, and LNG terminalling business. See our latest analysis for Fluxys Belgium. Despite a 1-day share price decline of 2.79% to €20.9 and some recent short-term weakness, the 90-day share price return of 9.42% and 1-year total shareholder return of 6.84% point to momentum that contrasts with weaker 3-...
BIT:TIT
BIT:TITTelecom

Is Telecom Italia (BIT:TIT) Still Attractive After A 95% One Year Share Price Surge

If you are wondering whether Telecom Italia's share price still offers value after a strong run, starting with a clear look at what you are paying for each euro of underlying fundamentals can help frame the decision. The stock last closed at €0.6242, with returns of 4.4% over 7 days, 1.8% over 30 days, 23.4% year to date, 95.1% over 1 year and 102.7% over 3 years, while the 5 year return stands at 43.5%. Recent coverage has focused on Telecom Italia's ongoing efforts to reshape its business...
BIT:BZU
BIT:BZUBasic Materials

Buzzi (BIT:BZU) Margin Decline Reinforces Bearish Narratives Despite Low P/E Discount

Buzzi (BIT:BZU) FY 2025 earnings snapshot Buzzi (BIT:BZU) has reported its FY 2025 first half results with revenue of €2.2b and basic EPS of €2.13, setting the tone for how the year is shaping up for shareholders. The company has seen revenue move from €2.1b in the first half of 2024 to €2.2b in the latest half, while basic EPS went from €2.28 to €2.13, against trailing twelve month EPS of €5.00 and revenue of €4.5b. These figures help frame the current performance in a broader context. With...
NYSE:AB
NYSE:ABCapital Markets

Is AllianceBernstein (AB) Quietly Redefining Its Wealth Strategy With Business Owner Segment Leadership?

In recent months, Bernstein Private Wealth Management, a unit of AllianceBernstein L.P., expanded Kim Mustin’s role to a national leadership position overseeing the firm’s Business Owner segment, which focuses on advising private business owners on selling and monetizing their companies. The firm also reported that new business in this segment is accelerating, with its first-quarter 2026 run rate already nearly one-third of the full-year 2025 total, highlighting how focused leadership can...
NasdaqGS:PATK
NasdaqGS:PATKAuto Components

What Patrick Industries (PATK)'s New Digital Twin Design Studio Means For Shareholders

In March 2026, Patrick Industries, Inc. unveiled The Experience, a collaborative digital design studio in its Elkhart, Indiana Design Center, anchored by a 50-by-14-foot ultra-high-resolution LED screen and a new Digital Twin process to help OEMs rapidly visualize and refine full-scale RV, marine, powersports, and housing products. This initiative highlights Patrick’s push to integrate advanced visualization and virtual prototyping into its offering, potentially tightening customer...
SEHK:2613
SEHK:2613Machinery

Contiocean Environment Tech Group SEHK 2613 Margin Compression Challenges High Growth Narrative

Contiocean Environment Tech Group (SEHK:2613) has released its FY 2025 numbers with first half revenue of C¥143.5 million and basic EPS of C¥0.18, set against trailing twelve month revenue of C¥421.4 million and EPS of C¥1.27. The company has seen revenue move from C¥336.5 million in the first half of FY 2024 and C¥277.9 million in the second half, while EPS shifted from C¥2.75 to C¥1.24 across those periods. This gives investors a clear view of how the latest figures sit against recent...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

A Look At GE HealthCare Technologies (GEHC) Valuation After FDA Clearance For Photonova Spectra CT System

GE HealthCare Technologies (GEHC) has put its Photonova Spectra photon-counting CT system in the spotlight after securing U.S. FDA 510(k) clearance, a regulatory milestone that validates commercial use for advanced cardiac imaging. See our latest analysis for GE HealthCare Technologies. The FDA 510(k) clearance for Photonova Spectra arrives after a period in which GE HealthCare’s 1 month share price return of 10.2% and year to date share price return of 13.09% have been weak. At the same...
NYSE:TDY
NYSE:TDYElectronic

Teledyne Deepens Defense And Space Focus With Royal Navy Deal

Teledyne Technologies (NYSE:TDY) has secured a major contract with the UK Ministry of Defence to supply autonomous ocean observing systems for the Royal Navy. The company has reorganized its space focused operations into a new initiative called Teledyne Space, combining multiple space related capabilities. These moves highlight Teledyne's focus on advanced maritime and space technologies that are closely tied to defense and national security needs. For investors tracking NYSE:TDY, the new...
NasdaqGS:LSCC
NasdaqGS:LSCCSemiconductor

A Look At Lattice Semiconductor (LSCC) Valuation After Earnings Beat And Strong AI-Focused Guidance

Earnings surprise and guidance put focus on Lattice Semiconductor Lattice Semiconductor (LSCC) drew attention after reporting quarterly revenue above expectations, tighter inventories, and data center strength linked to AI, while issuing next quarter revenue guidance that also topped analyst forecasts. See our latest analysis for Lattice Semiconductor. The latest results come after a sharp run in the share price, with a 90 day share price return of 29.85% and a 1 year total shareholder return...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Assessing Fiserv (FISV) Valuation As Litigation Concerns And Hold Ratings Shape Investor Caution

Recent shareholder litigation and board-level fiduciary duty questions have pushed Fiserv (FISV) into focus, as a class action complaint and law firm investigation intersect with cautious analyst ratings and a consensus Hold stance. See our latest analysis for Fiserv. At a share price of US$55.45, Fiserv has a 1 month share price return of 10.35% and a year to date share price return of 15.46%. The 1 year total shareholder return of 75.48% and 5 year total shareholder return of 54.96% point...
NasdaqGM:IOVA
NasdaqGM:IOVABiotechs

Iovance Biotherapeutics (IOVA) Is Down 6.5% After FDA Questions Amtagvi Marketing Claims Has The Bull Case Changed?

In March 2026, the FDA’s Center for Biologics Evaluation and Research issued an untitled letter to Iovance Biotherapeutics over Amtagvi promotional materials, citing potentially misleading references to overall survival data and giving the company 15 working days to respond. This regulatory pushback highlights the sensitivity around how Iovance communicates clinical outcomes for its first commercial product, a key element of its growth ambitions. We’ll now explore how the FDA’s concerns over...
NYSE:CTRE
NYSE:CTREHealth Care REITs

A Look At CareTrust REIT (CTRE) Valuation After Recent Share Price Moves

Context for CareTrust REIT after recent price moves CareTrust REIT (CTRE) has seen mixed share performance recently, with a gain of 1.3% over the past day, a small decline over the past week, and a larger drop over the past month. See our latest analysis for CareTrust REIT. That short term weakness sits alongside a 2.3% year to date share price return and a 35.5% total shareholder return over the past year, supported by even stronger 3 and 5 year total shareholder returns. If CareTrust REIT’s...
TSE:6762
TSE:6762Electronic

Assessing TDK (TSE:6762) Valuation After Recent Share Price Weakness

Recent performance snapshot TDK (TSE:6762) has drawn attention after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. See our latest analysis for TDK. The recent 6.15% 1 day and 13.53% year to date share price declines contrast with TDK's stronger 1 year and 3 year total shareholder returns of 38.84% and 128.38%. This suggests that momentum has cooled following a strong multi year period. If you...
TSE:4502
TSE:4502Pharmaceuticals

Does Takeda Pharmaceutical (TSE:4502) Still Offer Value After Strong Multi‑Year Share Price Gains?

If you are wondering whether Takeda Pharmaceutical's current share price lines up with its underlying worth, this breakdown is aimed squarely at you. The stock last closed at ¥5,890, with returns of 1.7% over 7 days, 2.8% over 30 days, 19.8% year to date, 35.0% over 1 year, 52.0% over 3 years, and 98.2% over 5 years, which gives plenty of recent performance data to weigh against valuation. Recent news coverage has focused on Takeda Pharmaceutical's position in the pharmaceutical sector and...
ENXTPA:AMUN
ENXTPA:AMUNCapital Markets

Does Amundi’s New COO and 2025 Disclosures Reframe Its Operational Edge Story (ENXTPA:AMUN)?

Amundi has filed its 2025 Universal Registration Document with the French regulator AMF, making updated financial, sustainability, governance and auditor-fee disclosures available to investors in both French and English. At the same time, the internal promotion of Cornil to Chief Operating Officer highlights Amundi’s focus on reinforcing its operational backbone within its asset management franchise. Next, we’ll examine how the COO appointment may influence Amundi’s existing investment...
NasdaqGS:TRIP
NasdaqGS:TRIPInteractive Media and Services

Is Tripadvisor (TRIP) Share Price Weakness Creating A Potential Opportunity For Investors?

If you are wondering whether Tripadvisor is a bargain at its current share price or cheap for a reason, this article breaks down what the market might be implying about its value. The stock last closed at US$10.71, with a 12.6% return over the past week and 7.3% over the past month, but a 26.8% decline year to date and a 25.2% decline over the past year. Recent headlines around Tripadvisor have focused on ongoing competition among travel platforms and how consumer behavior is evolving as...
BIT:RWAY
BIT:RWAYTelecom

Rai Way (BIT:RWAY) Valuation After Reduced Dividend And Softer Net Income Update

Why Rai Way's latest dividend and earnings update matters for shareholders Rai Way (BIT:RWAY) has put fresh numbers in front of investors, pairing its full year 2025 results with news of a reduced annual dividend of €0.33 per share, payable in May 2026. The combination of lower cash returns and pressure on net income has sharpened the focus on what investors are getting for every euro invested in the stock, especially with Rai Way operating as a pure play Italian tower and broadcasting...
NYSE:GRMN
NYSE:GRMNConsumer Durables

Garmin Fertility Tracking Deal With Natural Cycles Tests Wearables Valuation

Garmin (NYSE:GRMN) has entered a partnership with Natural Cycles to integrate FDA cleared fertility and reproductive health tracking into compatible Garmin smartwatches. The collaboration brings non hormonal birth control and detailed fertility insights to Garmin's wearable platform through Natural Cycles' approved algorithm. The integration extends Garmin's health tracking capabilities into reproductive health, targeting users seeking data driven support for cycle tracking and family...